Dr Andrew Brooks is the Group Leader of the Cytokine Receptor Signalling Group at the University of Queensland Diamantina Institute (UQ DI) within the Translational Research Institute. Andrew completed his Honours research on Flaviviruses in 1996 at the Department of Microbiology and Immunology at James Cook University and then moved to the Department of Biochemistry to study Dengue Virus where he completed his PhD in 2002. He then moved to St Jude Children’s Research Hospital in Memphis, TN, USA where he researched the role of Epstein-Barr Virus in B-cell lymphomagenesis. He then joined the research group headed by Prof Michael Waters at the Institute for Molecular Bioscience, UQ in 2006 and subsequently began his independent research group at UQ DI in 2014. Andrew’s research interests are in cytokine receptors, cell signalling, oncogenesis, and immunology. His current research focus is on the molecular mechanisms of class I cytokine receptor activation including the growth hormone receptor (GHR), thrombopoietin receptor (TpoR/MPL), IL-7 receptor, and IL-6 receptor (IL-6R). In addition, he is investigating the regulation of inflammation by HLA-G. His research has led to publications in journals including Science, Blood, Hepatology, Oncogene, Nature Cell Biology, and PNAS. He has been the secured of over $12 million in research and commercialisation funding from sources including NHMRC, ARC, Innovation Connections, and Merck. He has a number of national and international collaborations, a scientific founder of a start-up company, and is an Editorial Board member for the Journal Cancers and Human Cell. He was previously a committee member of Australian Early-Mid Career Researchers Forum (AEMCRF) launched by the Australian Academy of Science.
Quality of Research Outputs
In the last 10 years I have published in journals including Science, Nature Cell Biology, Blood, Oncogene, J Immunol, and Nature Reviews. I have over 1000 citations (Web of Knowledge or over 1500 Google Scholar) with an h-index of 16 (Web of Knowledge) or 19 (Google Scholar; i10-index 20). I have presented my research at a number of national (including as an invited speaker) and international (including as an invited speaker: Keystone JAK-STAT 2016, Biochemical Society 2016, US ENDO 2013, ICIS 2014) conferences.
Grant Success
In the last 5 year I have been awarded two NHMRC project grants as CIA awarded $919,834 for "Defining a general mechanism for class 1 cytokine receptor activation" and $494,050 for "HLA-G/H2-Bl is Critical for Regulating Inflammation in the Liver". I was also recently awarded an NHMRC project grant as CIB with Melissa and Matthew Call (WEHI) $667,521 for "The Structural Basis of Cytokine Receptor Triggering". In addition I was awarded a GGI award (Merck) (~$200,000) in 2016 for "Targeting the Growth Hormone Receptor Achilles’ Heel for Novel Therapeutics". I have also been a CI for three NHMRC project grants. These grants are: “Roles of the nuclear growth hormone receptor in cell proliferation and survival” awarded $414,925 in 2011, “Mechanism of activation of JAK2 by a class 1 cytokine receptor” awarded $543,675 in 2011, and “Constitutive activation of the growth hormone receptor” awarded $546,732 in 2010. In 2009 I was awarded a University of Queensland Early Career Researcher Grant for $20,000 (competitive written ARC style grant application) for “Establishment of an RCAS-TVA gene delivery system and in vivo analysis of growth hormone receptor signalling and its role in oncogenesis.”
Research Supervision and Mentoring
I have always had a strong role in supervising research higher degree (RHD) students. I have previously supervised 19 research students including two PhD students. I am currently supervising 3 PhD students. All of the students I have supervised are currently either continuing their research studies or are employed in their desired scientific field. I have given a number of lectures to undergraduate students to students at UQ since 2006. I am a member of the Translational Research Insititute Mentoring committee.
Community Engagement
I am actively involved in promoting my field to the general community and due to my standing have received multiple invitations for public engagement, including a radio interview (ABC: The World Today) and medical research information talks to community groups including the Northlakes Probus Club, Brisbane, 2015 and the Palm Lakes Lifestyle Village, Toowoomba, 2015 as part of a Cancer fundraiser. I have also received an invitation to present at an Educational Conference (Ausmed Education Australia) which will be attended by, health professionals and clinicians. I was previously a part of the IMB Science Ambassador program where I supervised High School work experience students in my research environment, gave tours of the IMB research facilities to students and members of the community, gave educational science demonstrations to a local primary school, as well as being part of “Scientists on the Loose” run by Australian Broadcasting Corporation which promotes science and science careers to regional high school students. I have attended the Talking Scientists Workshop in Brisbane which is a Queensland government initiative to engage Queensland scientists to talk about their work at branch meetings of community groups, and business associations, with the goal of showcasing your research, and getting the Queensland public thinking and talking about Queensland science. I have been a member of the Australian Early-Mid Career Researchers Forum.
Journal Article: Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning
Bridgford, Jessica L., Lee, Su Min, Lee, Christine M. M., Guglielmelli, Paola, Rumi, Elisa, Pietra, Daniela, Wilcox, Stephen, Chhabra, Yash, Rubin, Alan F., Cazzola, Mario, Vannucchi, Alessandro M., Brooks, Andrew J., Call, Matthew Edwin and Call, Melissa Joy (2020). Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning. Blood, 135 (4), 287-292. doi: 10.1182/blood.2019002561
Journal Article: Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7Rα cause receptor hypersensitivity
Campos, Livia Weijenborg, Zenatti, Priscila Pini, Pissinato, Leonardo Granato, Rodrigues, Gisele Olinto Libanio, Artico, Leonardo Luís, Guimarães, Thais Rafael, Archangelo, Leticia Fröhlich, Martínez, Leandro, Brooks, Andrew J. and Yunes, Jose Andres (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7Rα cause receptor hypersensitivity. Blood, 133 (11), 1259-1263. doi: 10.1182/blood-2018-09-872945
Journal Article: A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation
Chhabra, Y., Wong, H. Y., Nikolajsen, L. F., Steinocher, H., Papadopulos, A., Tunny, K. A., Meunier, F. A., Smith, A. G., Kragelund, B. B., Brooks, A. J. and Waters, M. J. (2018). A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation. Oncogene, 37 (4), 489-501. doi: 10.1038/onc.2017.352
Book Chapter: Cytokine receptors
Brooks, Andrew J., Dehkhoda, Farhad and Kragelund, Birthe (2018). Cytokine receptors. Endocrinology: principles of endocrinology and hormone action. (pp. 157-185) edited by Antonino Belfiore and Derek LeRoith. Amsterdam, The Netherlands: Springer. doi: 10.1007/978-3-319-44675-2_8
Journal Article: Mechanism of activation of protein kinase JAK2 by the growth hormone receptor
Brooks, Andrew J., Dai, Wei, O’Mara, Megan L., Abankwa, Daniel, Chhabra, Yash, Pelekanos, Rebecca A., Gardon, Olivier, Tunny, Kathryn A., Blucher, Kristopher M., Morton, Craig J., Parker, Michael W., Sierecki, Emma, Gambin, Yann, Gomez, Guillermo A., Alexandrov, Kirill, Wilson, Ian A., Doxastakis, Manolis, Mark, Alan E. and Waters, Michael J. (2014). Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344 (6185) 1249783, 1249783.1-1249783.12. doi: 10.1126/science.1249783
Journal Article: The growth hormone receptor: mechanism of activation and clinical implications
Brooks, Andrew J. and Waters, Michael J. (2010). The growth hormone receptor: mechanism of activation and clinical implications. Nature Reviews Endocrinology, 6 (9), 515-525. doi: 10.1038/nrendo.2010.123
Journal Article: An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway
Rowlinson, Scott W., Yoshizato, Hideo, Barclay, Johanna L., Brooks, Andrew J., Behncken, Stuart N., Kerr, Linda M., Millard, Kirstin, Palethorpe, Kathryn, Nielsen, Katherine, Clyde-Smith, Jodie, Hancock, John F. and Waters, Michael J. (2008). An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nature Cell Biology, 10 (6), 740-747. doi: 10.1038/ncb1737
Dr Andrew Brooks Research at UQ Diamantina Institute
(2020–2025) Kyon Biotech AG
Saving your skin: physiology of immune regulation in mammalian lymph nodes
(2020–2022) ARC Discovery Projects
CD14 inhibition in a Liver Inflammation mouse model
(2020–2021) Innovation Connections
(2020) Doctor Philosophy
Deciphering the structure and function of class I cytokine receptors: GHR and GP130
(2019) Doctor Philosophy
Pathogen Promoters of Squamous Epithelial Cancer
Doctor Philosophy
Bridgford, Jessica L., Lee, Su Min, Lee, Christine M. M., Guglielmelli, Paola, Rumi, Elisa, Pietra, Daniela, Wilcox, Stephen, Chhabra, Yash, Rubin, Alan F., Cazzola, Mario, Vannucchi, Alessandro M., Brooks, Andrew J., Call, Matthew Edwin and Call, Melissa Joy (2020). Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning. Blood, 135 (4), 287-292. doi: 10.1182/blood.2019002561
Campos, Livia Weijenborg, Zenatti, Priscila Pini, Pissinato, Leonardo Granato, Rodrigues, Gisele Olinto Libanio, Artico, Leonardo Luís, Guimarães, Thais Rafael, Archangelo, Leticia Fröhlich, Martínez, Leandro, Brooks, Andrew J. and Yunes, Jose Andres (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7Rα cause receptor hypersensitivity. Blood, 133 (11), 1259-1263. doi: 10.1182/blood-2018-09-872945
A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation
Chhabra, Y., Wong, H. Y., Nikolajsen, L. F., Steinocher, H., Papadopulos, A., Tunny, K. A., Meunier, F. A., Smith, A. G., Kragelund, B. B., Brooks, A. J. and Waters, M. J. (2018). A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation. Oncogene, 37 (4), 489-501. doi: 10.1038/onc.2017.352
Brooks, Andrew J., Dehkhoda, Farhad and Kragelund, Birthe (2018). Cytokine receptors. Endocrinology: principles of endocrinology and hormone action. (pp. 157-185) edited by Antonino Belfiore and Derek LeRoith. Amsterdam, The Netherlands: Springer. doi: 10.1007/978-3-319-44675-2_8
Mechanism of activation of protein kinase JAK2 by the growth hormone receptor
Brooks, Andrew J., Dai, Wei, O’Mara, Megan L., Abankwa, Daniel, Chhabra, Yash, Pelekanos, Rebecca A., Gardon, Olivier, Tunny, Kathryn A., Blucher, Kristopher M., Morton, Craig J., Parker, Michael W., Sierecki, Emma, Gambin, Yann, Gomez, Guillermo A., Alexandrov, Kirill, Wilson, Ian A., Doxastakis, Manolis, Mark, Alan E. and Waters, Michael J. (2014). Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344 (6185) 1249783, 1249783.1-1249783.12. doi: 10.1126/science.1249783
The growth hormone receptor: mechanism of activation and clinical implications
Brooks, Andrew J. and Waters, Michael J. (2010). The growth hormone receptor: mechanism of activation and clinical implications. Nature Reviews Endocrinology, 6 (9), 515-525. doi: 10.1038/nrendo.2010.123
Rowlinson, Scott W., Yoshizato, Hideo, Barclay, Johanna L., Brooks, Andrew J., Behncken, Stuart N., Kerr, Linda M., Millard, Kirstin, Palethorpe, Kathryn, Nielsen, Katherine, Clyde-Smith, Jodie, Hancock, John F. and Waters, Michael J. (2008). An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nature Cell Biology, 10 (6), 740-747. doi: 10.1038/ncb1737
Brooks, Andrew J., Dehkhoda, Farhad and Kragelund, Birthe (2018). Cytokine receptors. Endocrinology: principles of endocrinology and hormone action. (pp. 157-185) edited by Antonino Belfiore and Derek LeRoith. Amsterdam, The Netherlands: Springer. doi: 10.1007/978-3-319-44675-2_8
Brooks, Andrew J., Dehkhoda, Farhad and Kragelund, Birthe B. (2017). Cytokine Receptors. Endocrinology (Switzerland). (pp. 1-29) Springer Science and Business Media Deutschland GmbH. doi: 10.1007/978-3-319-27318-1_8-2
Growth hormone-binding proteins
Herington, Adrian C. and Brooks, Andrew J. (2014). Growth hormone-binding proteins. Reference module in biomedical research. (pp. 390-395) edited by Michael Caplan. Philadelphia, PA, United States: Elsevier. doi: 10.1016/B978-0-12-801238-3.04053-8
The interdomain region of dengue NS5 protein interacts with NS3 and host proteins
Brooks, Andrew J., Johansson, Magnus, Criswell, Erin, Jans, David A. and Vasudevan, Subhash G. (2002). The interdomain region of dengue NS5 protein interacts with NS3 and host proteins. Dengue Bulletin. (pp. 155-161) New Delhi, India.: WHO Regional Office for South-East Asia.
Chhabra, Yash, Seiffert, Pernille, Gormal, Rachel S., Vullings, Manon, Lee, Christine Mei Mei, Wallis, Tristan P., Dehkhoda, Farhad, Indrakumar, Sowmya, Jacobsen, Nina L., Lindorff-Larsen, Kresten, Durisic, Nela, Waters, Michael J., Meunier, Frederic A., Kragelund, Birthe B. and Brooks, Andrew J. (2023). Tyrosine kinases compete for growth hormone receptor binding and regulate receptor mobility and degradation. Cell Reports, 42 (5) 112490, 112490. doi: 10.1016/j.celrep.2023.112490
Germline missense variants in SH2B3 underpin platelet count variation and inherited MPN
Butler, Liesl, Lee, Christine, Magor, Graham William, Morris, Rhiannon, Tallack, Michael, Lam, Charlene, Ivey, Adam, Lin, Jane, Deng, Zihao, Grigg, Andrew, Mason, Jane, Perchard, Malaika, Weston, Helen, Cummings, Nik, Brooks, Andrew, Babon, Jeffrey J, Murphy, Andrew J, Salmon, Jessica M and Perkins, Andrew Charles (2022). Germline missense variants in SH2B3 underpin platelet count variation and inherited MPN. Blood, 140 (S1), 1093-1094. doi: 10.1182/blood-2022-159416
Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
Linossi, Edmond M., Li, Kunlun, Veggiani, Gianluca, Tan, Cyrus, Dehkhoda, Farhad, Hockings, Colin, Calleja, Dale J., Keating, Narelle, Feltham, Rebecca, Brooks, Andrew J., Li, Shawn S., Sidhu, Sachdev S., Babon, Jeffrey J., Kershaw, Nadia J. and Nicholson, Sandra E. (2021). Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands. Nature Communications, 12 (1) 7032, 7032. doi: 10.1038/s41467-021-26983-5
GHR signalling: Receptor activation and degradation mechanisms
Chhabra, Yash, Lee, Christine M. M., Mueller, Alexandra Franziska and Brooks, Andrew J. (2021). GHR signalling: Receptor activation and degradation mechanisms. Molecular and Cellular Endocrinology, 520 111075, 1-11. doi: 10.1016/j.mce.2020.111075
Brooks, Andrew J., Ishikawa, Mayumi, Fernández‐Rojo, Manuel A., Vivian, Julian P., Rossjohn, Jamie and Waters, Michael J. (2020). Reply to Letter to the Editors: Growth Hormone Stops Excessive Inflammation After Partial Hepatectomy Allowing Liver Regeneration and Survival by Induction of H2‐Bl/HLA‐G. Hepatology, 73 (3) hep.31531, 1239-1239. doi: 10.1002/hep.31531
JAK-STAT signalling pathway in cancer
Brooks, Andrew J. and Putoczki, Tracy (2020). JAK-STAT signalling pathway in cancer. Cancers, 12 (7) 1971, 1971-3. doi: 10.3390/cancers12071971
Ishikawa, Mayumi, Brooks, Andrew J., Fernández-Rojo, Manuel A., Medina, Johan, Chhabra, Yash, Minami, Shiro, Tunny, Kathryn A., Parton, Robert G., Vivian, Julian P., Rossjohn, Jamie, Chikani, Viral, Ramm, Grant A., Ho, Ken K. Y. and Waters, Michael J. (2020). Growth hormone stops excessive inflammation after partial hepatectomy allowing liver regeneration and survival via induction of H2-Bl/HLA-G. Hepatology, 73 (2) hep.31297, 759-775. doi: 10.1002/hep.31297
Bridgford, Jessica L., Lee, Su Min, Lee, Christine M. M., Guglielmelli, Paola, Rumi, Elisa, Pietra, Daniela, Wilcox, Stephen, Chhabra, Yash, Rubin, Alan F., Cazzola, Mario, Vannucchi, Alessandro M., Brooks, Andrew J., Call, Matthew Edwin and Call, Melissa Joy (2020). Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning. Blood, 135 (4), 287-292. doi: 10.1182/blood.2019002561
Chhabra, Yash, Nelson, Caroline N., Plescher, Monika, Barclay, Johanna L., Smith, Aaron G., Andrikopoulos, Sof, Mangiafico, Salvatore, Waxman, David J., Brooks, Andrew J. and Waters, Michael J. (2019). Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33 (5), fj201802328R-6430. doi: 10.1096/fj.201802328R
Campos, Livia Weijenborg, Zenatti, Priscila Pini, Pissinato, Leonardo Granato, Rodrigues, Gisele Olinto Libanio, Artico, Leonardo Luís, Guimarães, Thais Rafael, Archangelo, Leticia Fröhlich, Martínez, Leandro, Brooks, Andrew J. and Yunes, Jose Andres (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7Rα cause receptor hypersensitivity. Blood, 133 (11), 1259-1263. doi: 10.1182/blood-2018-09-872945
Dehkhoda, Farhad , Lee, Christine M. M. , Medina, Johan and Brooks, Andrew J. (2018). The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects. Frontiers in Endocrinology, 9 (35) 35, 35. doi: 10.3389/fendo.2018.00035
A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation
Chhabra, Y., Wong, H. Y., Nikolajsen, L. F., Steinocher, H., Papadopulos, A., Tunny, K. A., Meunier, F. A., Smith, A. G., Kragelund, B. B., Brooks, A. J. and Waters, M. J. (2018). A growth hormone receptor SNP promotes lung cancer by impairment of SOCS2-mediated degradation. Oncogene, 37 (4), 489-501. doi: 10.1038/onc.2017.352
De Angelis, Jessica E., Lagendijk, Anne K., Chen, Huijun, Tromp, Alisha, Bower, Neil I., Tunny, Kathryn A., Brooks, Andrew J., Bakkers, Jeroen, Francois, Mathias, Yap, Alpha S., Simons, Cas, Wicking, Carol, Hogan, Benjamin M. and Smith, Kelly A. (2017). Correction to: Tmem2 regulates embryonic Vegf signaling by controlling hyaluronic acid turnover (Developmental Cell 40, 2017, 123-136). Developmental Cell, 40 (4), 421-421. doi: 10.1016/j.devcel.2017.02.005
Tmem2 regulates embryonic Vegf signaling by controlling hyaluronic acid turnover
De Angelis, Jessica E., Lagendijk, Anne K., Chen, Huijun, Tromp, Alisha, Bower, Neil I., Tunny, Kathryn A., Brooks, Andrew J., Bakkers, Jeroen, Francois, Mathias, Yap, Alpha S., Simons, Cas, Wicking, Carol, Hogan, Benjamin M. and Smith, Kelly A. (2017). Tmem2 regulates embryonic Vegf signaling by controlling hyaluronic acid turnover. Developmental Cell, 40 (2), 123-136. doi: 10.1016/j.devcel.2016.12.017
STAT5 activation in the dermal papilla is important for hair follicle growth phase induction
Legrand, Julien M. D., Roy, Edwidge, Ellis, Jonathan J., Francois, Mathias, Brooks, Andrew J. and Khosrotehrani, Kiarash (2016). STAT5 activation in the dermal papilla is important for hair follicle growth phase induction. Journal of Investigative Dermatology, 136 (9), 1781-1791. doi: 10.1016/j.jid.2016.04.014
Stewart, Teneale A., Azimi, Iman, Brooks, Andrew J., Thompson, Erik W., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2016). Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells. The International Journal of Biochemistry and Cell Biology, 76, 64-74. doi: 10.1016/j.biocel.2016.05.007
Carey, Alison J., Sullivan, Matthew J., Duell, Benjamin L., Crossman, David K., Chattopadhyay, Debasish., Brooks, Andrew J., Tan, Chee K., Crowley, Michael., Sweet, Matthew J., Schembri, Mark A. and Ulett, Glen C. (2015). Uropathogenic Escherichia coli engages CD14-dependent signaling to enable bladder macrophage-dependent control of acute urinary tract infection. The Journal of infectious diseases, 213 (4), 659-668. doi: 10.1093/infdis/jiv424
Bugge, Katrine, Steinocher, Helena, Brooks, Andrew J., Lindorff-Larsen, Kresten and Kragelund, Birthe B. (2015). Exploiting Hydrophobicity for Efficient Production of Transmembrane Helices for Structure Determination by NMR Spectroscopy. Analytical Chemistry, 87 (18), 9126-9131. doi: 10.1021/acs.analchem.5b02365
Haxholm, Gitte W, Nikolajsen, Louise F, Olsen, Johan G, Fredsted, Jacob, Larsen, Flemming H, Goffin, Vincent, Pedersen, Stine F, Brooks, Andrew J, Waters, Michael J and Kragelund, Birthe B (2015). Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes. Biochemical Journal, 468 (3), 495-506. doi: 10.1042/BJ20141243
JAK2 activation by growth hormone and other cytokines
Waters, Michael J. and Brooks, Andrew J. (2015). JAK2 activation by growth hormone and other cytokines. Biochemical Journal, 466 (1), 1-11. doi: 10.1042/BJ20141293
Rewriting the mechanism of JAK2 activation
Brooks, Andrew J. and Waters, Michael J. (2015). Rewriting the mechanism of JAK2 activation. Cell Cycle, 14 (3), 285-286. doi: 10.1080/15384101.2015.1006533
Dingwall, Steven, Brooks, Andrew, Apte, Simon H., Waters, Mike, Lavin, Martin F. and Wolvetang, Ernst J. (2015). Expression of Histocompatibility 2 Blastocyst (H2-Bl) in embryonic stem cells inhibits CD8+ T-cell activation but is not sufficient to facilitate graft tolerance. Journal of Stem Cell Research and Therapy, 5 (12) 1000320, 1-8. doi: 10.4172/2157-7633.1000320
Waters, Michael J., Brooks, Andrew J. and Chhabra, Yash (2014). A new mechanism for growth hormone receptor activation of JAK2, and implications for related cytokine receptors. JAK-STAT, 3 (e29569), 1-6. doi: 10.4161/jkst.29569
Mechanism of activation of protein kinase JAK2 by the growth hormone receptor
Brooks, Andrew J., Dai, Wei, O’Mara, Megan L., Abankwa, Daniel, Chhabra, Yash, Pelekanos, Rebecca A., Gardon, Olivier, Tunny, Kathryn A., Blucher, Kristopher M., Morton, Craig J., Parker, Michael W., Sierecki, Emma, Gambin, Yann, Gomez, Guillermo A., Alexandrov, Kirill, Wilson, Ian A., Doxastakis, Manolis, Mark, Alan E. and Waters, Michael J. (2014). Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science, 344 (6185) 1249783, 1249783.1-1249783.12. doi: 10.1126/science.1249783
Why don't some dwarves get cancer?
Waters, Micheal and Brooks, Andrew (2014). Why don't some dwarves get cancer?. Australasian Science, 35 (9), 22-23.
Fernández Rojo, Manuel, Gongora, Milena, Fitzsimmons, Rebecca L., Martel, Nick, Martin, Sheree D., Nixon, Susan, Brooks, Andrew J., Ikonomopoulou, Maria P., Martin, Sally, Lo, Harriet P., Myers, Stephen A., Restall, Christina, Ferguson, Charles, Pilch, Paul F., McGee, Sean L., Anderson, Robin L., Waters, Michael J., Hancock, John F., Grimmond, Sean M., Muscat, George E. and Parton, Robert G. (2013). Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Reports, 4 (2), 238-247. doi: 10.1016/j.celrep.2013.06.017
Duell, Benjamin L., Carey, Alison J., Tan, Chee K., Cui, Xiangqin, Webb, Richard I., Totsika, Makrina, Schembri, Mark A., Derrington, Petra, Irving-Rodgers, Helen, Brooks, Andrew J., Cripps, Allan W., Crowley, Michael and Ulett, Glen C. (2012). Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. Journal of Immunology, 188 (2), 781-792. doi: 10.4049/jimmunol.1101231
Role of the growth hormone–IGF-1 axis in cancer
Chhabra, Yash, Waters, Michael J. and Brooks, Andrew J. (2011). Role of the growth hormone–IGF-1 axis in cancer. Expert Review of Endocrinology and Metabolism, 6 (1), 71-84. doi: 10.1586/eem.10.73
The growth hormone receptor: mechanism of activation and clinical implications
Brooks, Andrew J. and Waters, Michael J. (2010). The growth hormone receptor: mechanism of activation and clinical implications. Nature Reviews Endocrinology, 6 (9), 515-525. doi: 10.1038/nrendo.2010.123
Conway-Campbell, B. L., Brooks, A. J., Robinson, P. J., Perani, M. and Waters, M. J. (2008). The extracellular domain of the growth hormone receptor interacts with coactivator to promote cell proliferation. Molecular Endocrinology, 22 (9), 2190-2202. doi: 10.1210/me.2008-0128
Rowlinson, Scott W., Yoshizato, Hideo, Barclay, Johanna L., Brooks, Andrew J., Behncken, Stuart N., Kerr, Linda M., Millard, Kirstin, Palethorpe, Kathryn, Nielsen, Katherine, Clyde-Smith, Jodie, Hancock, John F. and Waters, Michael J. (2008). An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nature Cell Biology, 10 (6), 740-747. doi: 10.1038/ncb1737
Growth hormone receptor; mechanism of action
Brooks, Andrew J., Wooh, Jong Wei, Tunny, Kathryn A. and Waters, Michael J. (2008). Growth hormone receptor; mechanism of action. The International Journal of Biochemistry and Cell Biology, 40 (10), 1984-1989. doi: 10.1016/j.biocel.2007.07.008
Conway-Campbell, B., Wooh, J., Brooks, A., Gordon, D, Brown, R. J., Lichanska, A. M., Chin, H., Barton, C., Boyle, G., Parsons, P., Jans, D. A. and Waters, M. J. (2007). Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis. Proceedings of The National Academy of Sciences of The United States of America, 104 (33), 13331-13336. doi: 10.1073/pnas.0600181104
Jiménez-Ramírez, Carmilia, Brooks, Andrew J., Forshell, Linus Plym, Yakimchuk, Konstantin, Zhao, Bo, Fulgham, Tacha Zi and Sample, Clare E. (2006). Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter. Journal of Virology, 80 (22), 11200-11208. doi: 10.1128/JVI.00897-06
The interdomain region of dengue NS5 protein interacts with NS3 and host proteins
Brooks, Andrew J., Johansson, Magnus, Criswell, Erin, Jans, David A. and Vasudevan, Subhash G. (2002). The interdomain region of dengue NS5 protein interacts with NS3 and host proteins. Dengue Bulletin, 26, 155-161.
Brooks, Andrew J., Johansson, Magnus, John, Anna V., Xu, Yibin, Jans, David A. and Vasudevan, Subhash G. (2002). The Interdomain Region of Dengue NS5 Protein That Binds to the Viral Helicase NS3 Contains Independently Functional Importin beta 1 and Importin alpha /beta -Recognized Nuclear Localization Signals. Journal of Biological Chemistry, 277 (39), 36399-36407. doi: 10.1074/jbc.M204977200
Johansson, Magnus, Brooks, Andrew J., Jans, David A. and Vasudevan, Subhash G. (2001). A small region of the dengue virus-encoded RNA-dependent RNA polymerase, NS5, confers interaction with both the nuclear transport receptor importin-β and the viral helicase, NS3. Journal of General Virology, 82 (4), 735-745. doi: 10.1099/0022-1317-82-4-735
Vasudevan, Subhash G., Johansson, Magnus, Brooks, Andrew J., Llewellyn, Lyndon E. and Jans, David A. (2001). Characterisation of inter- and intra-molecular interactions of the dengue virus RNA dependent RNA polymerase as potential drug targets. Farmaco, 56 (1-2), 33-36. doi: 10.1016/S0014-827X(01)01014-X
Forwood, Jade K., Brooks, Andrew, Briggs, Lyndall J., Xiao, Chong-Yun, Jans, David A. and Vasudevan, Subhash G. (1999). The 37-amino-acid interdomain of dengue virus NS5 protein contains a functional NLS and inhibitory CK2 site. Biochemical and Biophysical Research Communications, 257 (3), 731-737. doi: 10.1006/bbrc.1999.0370
Dang, T. V. T., Gillinder, K. G., Brooks, A. J., Asplett, K., Tolley, L. K., Hume, D. A., Leggatt, G. R., Frazer, I. H. and Chandra, J. (2022). Gene-therapy based modulation of antigen-presenting cells within hyperproliferative epithelium to restore immunity. 29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT), Edinburgh, United Kingdom, 11-14 October 2022. New Rochelle, NY United States: Mary Ann Liebert.
Specific domains of LNK (SH2B3) bind and regulate TPOR stability and signalling
Lee, Christine, Brooks, Andrew, Chhabra, Yash and Perkins, Andrew (2019). Specific domains of LNK (SH2B3) bind and regulate TPOR stability and signalling. 48th Annual Scientific Meeting of the Society for Experimental Hematology, Brisbane, Australia, 22-25 August 2019. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.exphem.2019.06.387
Brooks, Andrew, Campos, Livia, Lee, Christine, Chhabra, Yash, Bridgford, Jessica, Lee, Su Min, Zenatti, Priscila, Pissinato, Leonardo, Rodrigues, Gisele, Artico, Leonardo, Guimarães, Thais, Archangelo, Leticia, Martínez, Leandro, Slape, Christopher, Call, Matthew, Call, Melissa and Yunes, José (2019). The mechanism of oncogenic mutations in the juxtamembrane and transmembrane region of IL7RA and TPOR/MPL. ISEH 2019, Brisbane, Australia, 22-25 August 2019. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.exphem.2019.06.332
Class I cytokine receptors: towards the inside
Steinocher, Helena, Bugge, Katrine, Nikolajsen, Louise Fletcher, Lindorff-Larsen, Kresten, Brooks, Andrew and Kragelund, Birthe Brandt (2017). Class I cytokine receptors: towards the inside. 61st Annual meeting of the Biophysical Society, New Orleans, LA, United States, 11-15 February 2017. St. Louis, MO United States: Cell Press. doi: 10.1016/j.bpj.2016.11.947
Going downstream - how does GH binding activate JAK2
Brooks, Andrew, Dai, W., O'Mara, M. L., Abankwa, D., Chhabra, Y., Pelekanos, R. A., Gardon, O., Tunny, K. A., Blucher, K. M., Morton, C. J., Parker, M. W., Sierecki, E., Gambin, Y., Gomez, G. A., Alexandrov, K., Wilson, I. A., Doxastakis, M., Mark, A. E. and Waters, M. J. (2016). Going downstream - how does GH binding activate JAK2. Annual Scientific Meeting of the Endocrine Society of Australia, Adelaide, Australia, 23-26 August, 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/cen.13010
Mechanism of JAK2 Activation by the Archetype Class I Cytokine Receptor, the Growth Hormone Receptor
Brooks, Andrew J., O’Mara, Megan L., Dai, Wei, Abankwa, Daniel, Chhabra, Yash, Tunny, Kathryn A., Parker, Michael W., Sierecki, Emma, Gambin, Yann, Gomez, Guillermo A., Haxholm, Gitte W., Nikolajsen, Louise F., Doxastakis, Manolis, Mark, Alan E. and Waters, Michael J. (2016). Mechanism of JAK2 Activation by the Archetype Class I Cytokine Receptor, the Growth Hormone Receptor. Biophysical Meeting, Los Angeles, CA, United States, 27 February - 2 March 2016. CAMBRIDGE: CELL PRESS. doi: 10.1016/j.bpj.2015.11.233
Stewart, Teneale A., Azimi, Iman, Davis, Felicity M., Thompson, Erik W., Brooks, Andrew J., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2015). A potential role for Janus protein tyrosine kinases in the regulation of epithelial-mesenchymal transition in a model of epidermal growth factor induced breast cancer epithelial-mesenchymal transition. 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX United States, 9-13 December 2014. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS14-P2-07-05
A new cytokine receptor activation paradigm: Activation of JAK2 by the growth hormone receptor
Brooks, Andrew J, Chhabra, Yash, Abankwa, Daniel, O’Mara, Megan, Dai, Wei, Gardon, Olivier, Tunny, Kathryn A., Blucher, Kristopher M., Morton, Craig J., Parker, Michael W., Sierecki, Emma, Gambin, Yann, Guillermo A. Gomez, Alexandrov, Kirill Kirill, Doxastakis, Manolis, Mark, Alan E. and Waters, Michael J. (2014). A new cytokine receptor activation paradigm: Activation of JAK2 by the growth hormone receptor. 2nd Annual Meeting of the International Cytokine and Interferon Society (ICIS), Melbourne, VIC Australia, 26 - 29 October 2014. London, United Kingdom: Academic Press. doi: 10.1016/j.cyto.2014.07.227
Bassett, John J., Stewart, Teneale A., Azimi, Iman , Davis, Felicity M., Thompson, Erik W., Brooks, Andrew J., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2014). Assessment of Janus protein tyrosine kinases as potential regulators of epithelial-mesenchymal transition using a model of epidermal growth factor induced breast cancer epithelial-mesenchymal transition. ASCEPT-MPGPCR Joint Scientific Meeting, Melbourne, VIC Australia, 7-11 December 2014.
Mechanism of activation of JAK2 by growth hormone
Waters, M. J. and Brooks, A. J. (2014). Mechanism of activation of JAK2 by growth hormone. Seventh International Congress of the GRS and the IGF Society, Singapore, 17-20 October 2014. London, United Kingdom: Churchill Livingstone. doi: 10.1016/S1096-6374(14)50035-4
The first cancer-associated variant of the growth hormone receptor
Chhabra, Yash, Wong, Ho Yi, Brooks, Andrew James and Waters, Michael John (2014). The first cancer-associated variant of the growth hormone receptor. Endocrine Society's 96th Annual Meeting and Expo, Chicago, IL, United States, 21-24 June 2014. WASHINGTON: Endocrine Society.
Growth hormone and cell growth
Waters, Michael J. and Brooks, Andrew J. (2012). Growth hormone and cell growth. 6th ESPE Advanced Seminar in Developmental Endocrinology, Bern, Switzerland, 10-11 May 2012. Basel, Switzerland: S. Karger. doi: 10.1159/000341761
Hepatic IGF-I production is regulated by Kupffer cells
Ishikawa, M., Barclay, J. L., Brooks, A. J., McPhee, T. R., Yoshino, G. and Waters, M. J. (2012). Hepatic IGF-I production is regulated by Kupffer cells. Sixth International Congress of the GRS and the IGF Society, Munich, Germany, 17-20 October 2012. London, United Kingdom: Churchill Livingstone. doi: 10.1016/S1096-6374(12)60056-2
Growth hormone receptor: structure function relationships
Waters, Michael J. and Brooks, Andrew J. (2011). Growth hormone receptor: structure function relationships. Switzerland: S. Karger AG. doi: 10.1159/000329138
Role of growth hormone signaling pathways in liver regeneration
Ishikawa, M., McPhee, T. R., Barclay, J. L., Fernandez-Rojo, M., Brooks, A. J. and Waters, M. J. (2010). Role of growth hormone signaling pathways in liver regeneration. Fifth International congress of the GRS and the IGF Society, New York, NY, United States, 3-7 October. London, United Kingdom: Churchill Livingstone. doi: 10.1016/S1096-6374(10)70011-3
Dr Andrew Brooks Research at UQ Diamantina Institute
(2020–2025) Kyon Biotech AG
Saving your skin: physiology of immune regulation in mammalian lymph nodes
(2020–2022) ARC Discovery Projects
CD14 inhibition in a Liver Inflammation mouse model
(2020–2021) Innovation Connections
(2019–2021) Walter & Eliza Hall Institute of Medical Research (WEHI)
HLA-G/H2-Bl is Critical for Regulating Inflammation in the Liver
(2017–2020) NHMRC Project Grant
Hardy Brothers Scholarship for Research in Blood Cancer at the UQ Diamantina Institute
(2016–2019) Hardy Brothers
Targeting the growth hormone receptor Achilles' heel for novel therapeutics
(2016–2019) Grant for Growth Innovation
A New Paradigm for Class I Cytokine Receptor Activation
(2015–2018) NHMRC Project Grant
Mechanism of activation of JAK2 by a class 1 cytokine receptor
(2012–2015) NHMRC Project Grant
Roles of the nuclear growth hormone receptor in cell proliferation and survival
(2012–2014) NHMRC Project Grant
Constitutive activation of the growth hormone receptor
(2011–2013) NHMRC Project Grant
COMPARATIVE ANTI-BACTERIAL IMMUNITY IN THE URINARY TRACT: DOES ONE SIZE FIT ALL?
(2009–2011) NHMRC Project Grant
(2009) UQ Early Career Researcher
Pathogen Promoters of Squamous Epithelial Cancer
Doctor Philosophy — Associate Advisor
Understanding the regulatory nature of CD8+/CD4+ Double-positive T-cells
Doctor Philosophy — Associate Advisor
Other advisors:
(2020) Doctor Philosophy — Principal Advisor
Deciphering the structure and function of class I cytokine receptors: GHR and GP130
(2019) Doctor Philosophy — Principal Advisor
Other advisors:
Mesenchymal-Epidermal Interactions in Hair Follicle Cycling and Regeneration
(2015) Doctor Philosophy — Associate Advisor
Other advisors:
The Growth Hormone Receptor Mediated Oncogenesis
(2014) Doctor Philosophy — Associate Advisor
Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.